 CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., March 04, 2021 GLOBE NEWSWIRE -- F-star Therapeutics, Inc. NASDAQ: FSTX, a clinical-stage biopharmaceutical company dedicated to developing next generation immunotherapies to transform the lives of patients with cancer, today announced that the companys management team will participate in the H.C. Wainwright Global Life Science Conference and the Oppenheimer Co 31st Annual Healthcare Conference. Both events will take place virtually. 